• Sign up
  • Login

Scheme Profile

ICICI Pru P.H.D Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
4,915
Inception Date
13-07-2018
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 40.39 (02-Jan-2025) / 29.85 (09-May-2024)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 37.33 ( 0.06) ( 0.16 %)
  • Benchmark
  • BSE Healthcare TRI
  • Entry Load
  • Nil
  • Exit Load
  • 1.00% - If units purchased or switched in from another scheme of the fund are redeemed or switched out within 15 Days from the date of allotment Nil - If units purchased or switched in from another scheme of the fund are redeemed or switched out after 15 Days from the date of allotment
  • Expense Ratio (%)
  • 2.07
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 38.04 times
  • Portfolio P/B
  • 6.22 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.83

Risk Factors

  • Jenson's Alpha
  • 12.22
  • Standard Deviation
  • 4.69
  • Beta
  • 0.84
  • Sharpe
  • 0.96
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.10

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Mar 2025 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 38,24,250
  • 13.50
  • Dr Reddys Laboratories Ltd
  • Equity
  • 38,42,525
  • 8.95
  • Cipla Ltd
  • Equity
  • 30,15,025
  • 8.85
  • Divis Laboratories Ltd
  • Equity
  • 5,70,624
  • 6.71
  • Aurobindo Pharma Ltd
  • Equity
  • 22,44,911
  • 5.30

Sector Top 5 Holdings

  [ As on 31 Mar 2025 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 3,34,64,119
  • 82.17
  • Healthcare
  • 37,54,324
  • 7.28
  • Chemicals
  • 23,26,138
  • 4.63
  • Insurance
  • 13,73,970
  • 2.17
  • Retail
  • 9,96,959
  • 1.57

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD -7.30 -7.69 0 2.21 4,914.64
2024 47.43 34.92 10.35 8.12 5,320.29
2023 41.68 31.12 38.35 18.10 3,361.31
2022 -8.28 -9.58 -11.31 2.80 2,513.92
2021 17.63 17.96 20.57 21.69 2,963.80
2020 70.88 65.84 62.19 15.60 2,159.31
2019 4.44 4.22 -3.06 13.79 1,286.90
2018 -1.20 -2.00 -5.45 6.67 1,468.28

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Mar-2025 -10.11 -8.95 0 0 4,914.64
Dec-2024 2.77 1.62 0 0 5,320.29
Sep-2024 20.51 19.55 0 0 4,987.49
Jun-2024 5.19 3.76 0 0 4,125.26

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Quick links

Close